跳至主要内容
临床试验/NCT00361322
NCT00361322已完成1 期

Topical Clindamycin Salicylic Acid Preparation for the Treatment of Acne Vulgaris

Hadassah Medical Organization2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2005年4月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
40
试验地点
2
主要终点
Lesions count at the end of study (week 8)

研究概览

简要总结

The concept behind our study was to combine an effect of antibiotic and anti-inflammatory agents for a more efficient acne therapy directed at the factors involved in the pathophysiology of the disease. For this purpose we evaluated a combination of clindamycin phosphate and salicylic acid in a non-irritating carrier.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • mild to moderate acne vulgaris;
  • at least 5 lesions on the face;
  • a one-month wash-out period was established for any topical or systemic drug use for treatment of acne vulgaris.

排除标准

  • acne that was primarily truncal, nodular, or due to secondary causes/internal disease;
  • pregnancy, breastfeeding, or intention to become pregnant;
  • another dermatological disease of the face;
  • significant systemic disease;
  • any drug/alcohol addiction;
  • interacting medication;
  • known hypersensitivity to study medications;
  • history of chronic disease treated with medications which might affect acne condition and treatment outcome (e.g. corticosteroids, lithium, isoniazid, anti-androgens, phenytoin, phenobarbital) in the preceding month

结局指标

主要结局

Lesions count at the end of study (week 8)

Lesions count at the baseline (week 0)

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验